Article Text

Download PDFPDF
Correspondence on ‘Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome’ by Silverio et al
  1. John E Madias
  1. Cardiology, Icahn School of Medicine at Mount Sinai/Cardiology Division, Elmhurst Hospital Center, Elmhurst, New York, USA
  1. Correspondence to Professor John E Madias, Cardiology, Icahn School of Medicine at Mount Sinai/Cardiology Division, Elmhurst Hospital Center, Elmhurst, NY 11373, USA; madiasj{at}nychhc.org

Statistics from Altmetric.com

To the Editor I enjoyed reading the article by Silverio et al,1 pertaining to the long-term (median follow-up of 24.0 months) effects of β-blocker therapy in patients with takotsubo syndrome (TTS). The authors employed a consecutive patient database of 825, studied over a 12-year period, mostly female in their early 60s to late 70s from the Takotsubo Italian Network (TIN) registry, about 60% of whom were discharged on β-blockers, while the balance of patients did not receive such …

View Full Text

Footnotes

  • Contributors JEM is the sole contributor.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles